Understanding of the LEADR-regulated differentiation program would therefore help clarify the mechanisms of tumor initiation in prostate cancer, and could be also translated to other tumor types, such as breast cancer, where basal–luminal transitions have been shown to be relevant hallmarks. The gene discussed is MIR205HG; the disease is breast cancer.